Clinical Trials
7 trialsNCT06019468 2026-05-08
Neoadjuvant Treatment For Locally Advanced Thymic Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Recruiting
NCT07559864 2026-04-30
Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment
Peking University Cancer Hospital & Institute
Phase 2 Recruiting
NCT07260305 2026-04-24
A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients
Kangabio AUSTRALIA LTD PTY
Phase 1 Recruiting
NCT03667170 2026-03-25
KN035 for dMMR/MSI-H Advanced Solid Tumors
3D Medicines
Phase 2 Recruiting
NCT04891198 2026-03-25
ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
3D Medicines
Phase 2 Recruiting
NCT05024214 2026-03-25
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
3D Medicines
Phase 1/2 Recruiting
NCT05112991 2026-03-25
Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
3D Medicines
Phase 2 Recruiting